Drugs / MTX
last change Dec 2023 re-read 2 minutes ago

MTX

Developed for
gestational trophoblastic neoplasm

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT03885388 Comparator Mar 2019 → Dec 2021 chemotherapy-induced toxicity, gestational trophoblastic neoplasm Women's Hospital School Of Medicine Zhejiang University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MTX ClinicalTrials.gov intervention name — accepted as the source's own label NCT03885388
Route Intramuscular intramuscularNCT03885388